Personalizing Cancer Treatment
with
ARTIFICIAL INTELLIGENCE
with
ARTIFICIAL INTELLIGENCE
Rory has a master's in biomedical science and is a self-taught machine-learning practitioner. Over the last decade, he has been actively involved in the startup scene, serving as both a founder and an early employee. During this time, he has gained experience in various sectors such as sports, healthcare, and open-source software.
Sheraton is an experienced Chief Technology Officer with expertise in complex systems modelling and medical image processing. Sheraton holds two Doctor of Philosophy (PhD) degrees—one in Computational Science from the University of Amsterdam and another in Health Technology from Nanyang Technological University.
Onkolyze is dedicated to crafting digital solutions that empower medical professionals in tailoring cancer treatments to individual patients. Our approach integrates cutting-edge technologies, including machine learning, complexity science, and computational fluid dynamics, to provide innovative tools that enhance the personalization of cancer care.
